![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Pharmacia & Upjohn Company Kalamazoo Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Methylprednisolone hydrogen succinate, (or Methylprednisolone hemisuccinate), supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2000-365 - Rev 00
This TSE Type CEP, issued on November 16, 2001, remains in force until November 16, 2006, ensuring its reliability within the pharmaceutical industry.
Substance Number 1131 associated with this CEP further emphasizes